China opens STAR Market IPOs to unprofitable AI firms

Key Takeaways

• Shanghai Stock Exchange now allows unprofitable AI and hard-tech startups to list under new 'Fifth Listing Standard'
• Targeted sectors include quantum technology, nuclear fusion, brain-computer interfaces, and robotics
• Move comes as U.S. markets prepare major IPOs from SpaceX, OpenAI, and Anthropic

China's securities regulators and the Shanghai Stock Exchange released new rules Wednesday that let AI large-model companies and other unprofitable tech startups go public on the STAR Market. The policy shift, effective immediately, removes profitability requirements for firms in what Beijing calls "future industries," including quantum technology, nuclear fusion, and brain-computer interfaces.

The timing is deliberate. Wall Street is gearing up for major IPOs from SpaceX, OpenAI, and Anthropic. Beijing wants domestic capital markets to capture homegrown AI champions before they look offshore.

What changed in China's AI IPO rules?

The Shanghai Stock Exchange activated what it calls the "Fifth Listing Standard." Traditional IPO requirements in China demand past profitability. This new framework evaluates companies instead on R&D capability, market value, and strategic importance to the national industrial chain.

Wu Qing, chairman of the China Securities Regulatory Commission, framed the move in competitive terms at a Shanghai forum Wednesday.

“A new wave of technological revolution, led by AI, is being integrated into production and daily life at an unprecedented pace. Major capital markets around the world are accelerating reforms to better adapt to the needs of innovation and gain leading positions.”

— Wu Qing, Chairman, China Securities Regulatory Commission

The exchange explicitly stated that supporting listings in emerging and future industries is a "major task" aligned with China's next five-year economic development plan. The targeted sectors go beyond AI: hydrogen energy, biomedical engineering, and robotics all qualify.

Which companies are lining up?

Several high-profile Chinese tech firms are already positioning for domestic listings. ChangXin Memory Technologies, a memory-chip giant, and Unitree Robotics, a robot maker, are preparing to float on domestic exchanges.

The new rules appear designed to attract AI unicorns that might otherwise list in Hong Kong or New York. Zhipu AI raised $558 million in its January 2026 Hong Kong IPO and is reportedly exploring a STAR Market dual-listing. MiniMax raised $619 million in its own January 2026 debut, setting expectations for what "hard tech" valuations look like under the new standards.

How does 'patient capital' fit in?

Wu said regulators will guide more long-term "patient" capital into equity investments. The phrase signals a push for institutional and state-owned funds to back companies that need years of R&D before turning profitable.

A CSRC spokesperson reinforced the message: "The capital market must actively embrace the new phase of technological revolution, providing patient capital for enterprises that carry the future of our national industrial chain."

This is not China's first capital-market reform for innovative tech. The CSRC had already adjusted rules to facilitate listings by AI chipmakers and rocket developers. The new guidelines formalize and expand that approach.

What's the risk?

Dropping profitability requirements creates obvious hazards. The STAR Market, launched in 2019, was designed for tech innovation but has seen volatility when speculative listings disappointed. Allowing companies with no path to near-term profit invites more of that.

Discussion on platforms like Reddit's r/ChinaTech and Hacker News has focused on whether this replicates U.S.-style VC-backed growth or sets up a bubble. Analysts note the success depends heavily on whether state-owned and institutional funds provide genuine liquidity, not just headline numbers.

There's also the question of whether top AI startups like DeepSeek and Moonshot will actually choose onshore listings over offshore options that offer global investor access and different regulatory oversight.

Why this matters beyond China

The Sino-U.S. tech rivalry now extends to capital markets. Beijing is betting that keeping its best AI companies listed domestically strengthens national control and funnels Chinese savings into strategic sectors. Washington's own approach, letting private companies stay private longer while VCs capture the upside, has drawn criticism for shutting retail investors out of growth stories.

China's move is an explicit counter. Whether the STAR Market can match NASDAQ's liquidity and price discovery for early-stage tech remains the open question.

Frequently Asked Questions

What is the Fifth Listing Standard on China's STAR Market?

A new framework that allows companies with strategic technology but no profits to list, assessed on R&D maturity and market value instead of earnings.

Which industries qualify under China's new IPO rules?

AI large-model companies, quantum technology, nuclear fusion, brain-computer interfaces, hydrogen energy, biomedical engineering, and robotics.

When do China's new AI IPO rules take effect?

The rules are effective immediately as of their announcement on Wednesday.

What is 'patient capital' in China's tech investment context?

Long-term equity investment, often from state-owned or institutional funds, designed to support companies through years of R&D before profitability.

Source: Tech-Economic Times / ET